DURECT Corporation (DRRX) financial statements (2022 and earlier)

Company profile

Business Address 10260 BUBB RD
CUPERTINO, CA 95014
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments69,81080,79688,43097,08340,73348,61351,145
Cash and cash equivalents49,84455,41256,07357,54521,31218,67018,446
Short-term investments19,96625,38432,35739,53819,42129,94332,699
Receivables6,4779468169939401,4921,997
Inventory, net of allowances, customer advances and progress billings1,8702,2701,9181,9551,8643,6283,460
Inventory1,8702,2701,9181,9551,8643,6283,460
Other undisclosed current assets3,5803,2384,1924,78019,5243,1343,481
Total current assets:81,73787,25095,356104,81163,06156,86760,083
Noncurrent Assets
Operating lease, right-of-use asset3,4463,7894,1204,4404,7495,0485,372
Property, plant and equipment227343211224251430476
Long-term investments and receivables    1,0001,000 
Long-term investments    1,0001,000 
Intangible assets, net (including goodwill)6,1696,1696,1696,1696,1696,3996,399
Goodwill6,1696,1696,1696,1696,1696,3996,399
Restricted cash and investments150150150150150150150
Other noncurrent assets261261261261261261283
Total noncurrent assets:10,25310,71210,91111,24412,58013,28812,680
TOTAL ASSETS:91,99097,962106,267116,05575,64170,15572,763
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:6,7997,6356,2006,2447,4795,7715,707
Accounts payable 1,8941,0862,1501,6781,1062,015
Accrued liabilities 5,7415,1144,0945,8014,6653,692
Employee-related liabilities4,099      
Other undisclosed accounts payable and accrued liabilities2,700      
Deferred revenue98 5373   
Debt   2,895884  
Other undisclosed current liabilities3,1591,9302,0132,1922,3403,7854,645
Total current liabilities:10,0569,5658,21811,70410,7039,55610,352
Noncurrent Liabilities
Long-term debt and lease obligation22,45622,68622,90120,94323,13824,18724,366
Long-term debt, excluding current maturities20,63220,49620,36018,06219,93620,67920,539
Operating lease, liability1,8242,1902,5412,8813,2023,5083,827
Liabilities, other than long-term debt1,6961,6841,6851,6851,6851,7141,703
Deferred revenue812812812812812812812
Other liabilities884872873873873902891
Total noncurrent liabilities:24,15224,37024,58622,62824,82325,90126,069
Total liabilities:34,20833,93532,80434,33235,52635,45736,421
Stockholders' equity
Stockholders' equity attributable to parent57,78264,02773,46381,72340,11534,69836,342
Common stock23232323202019
Additional paid in capital583,818583,043582,505581,632529,884528,804521,064
Accumulated other comprehensive income (loss)(10)2(1)(14)(5)1871
Accumulated deficit(526,049)(519,041)(509,064)(499,918)(489,784)(494,144)(484,812)
Total stockholders' equity:57,78264,02773,46381,72340,11534,69836,342
TOTAL LIABILITIES AND EQUITY:91,99097,962106,267116,05575,64170,15572,763

Income statement (P&L) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Revenues7,2972,1652,3032,212(1,191)2,68325,844
Cost of revenue(891)(364)(359)(352)1,855(1,065)(964)
Cost of goods and services sold (364)(359)(352)1,855(1,065)(964)
Gross profit:6,4061,8011,9441,8606641,61824,880
Operating expenses(12,918)(11,259)(10,601)(11,506)(9,550)(10,488)(10,125)
Operating income (loss):(6,512)(9,458)(8,657)(9,646)(8,886)(8,870)14,755
Nonoperating expense(496)(519)(489)(488)(507)(462)(417)
Other nonoperating income463439374084135
Interest and debt expense(542)(553)(528)(525)(547)(546)(552)
Income (loss) from continuing operations before income taxes:(7,550)(10,530)(9,674)(10,659)(9,940)(9,878)13,786
Other undisclosed income from continuing operations542553 5252,237  
Income (loss) from continuing operations:(7,008)(9,977)(9,674)(10,134)(7,703)(9,878)13,786
Other undisclosed income before gain (loss) on sale of properties    13,753  
Income (loss) before gain (loss) on sale of properties:(7,008)(9,977)(9,674)(10,134)6,050(9,878)13,786
Other undisclosed net loss    (1,690)  
Net income (loss):(7,008)(9,977)(9,674)(10,134)4,360(9,878)13,786
Other undisclosed net income attributable to parent  528  546552
Net income (loss) available to common stockholders, diluted:(7,008)(9,977)(9,146)(10,134)4,360(9,332)14,338

Comprehensive Income ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Net income (loss):(7,008)(9,977)(9,674)(10,134)4,360(9,878)13,786
Comprehensive income (loss):(7,008)(9,977)(9,674)(10,134)4,360(9,878)13,786
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(12)3541(9)(23)493641
Comprehensive income (loss), net of tax, attributable to parent:(7,020)(9,974)(9,133)(10,143)4,337(9,385)14,427

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: